Pharmaceutical intermediates
Ropivacaine Hydrochloride Hydrate Intermediates
2 pharmaceutical intermediates for Ropivacaine Hydrochloride Hydrate. Indication: Anesthesia.
About Ropivacaine Hydrochloride Hydrate
- Originator
- Astrazeneca
- Indication
- Anesthesia
- Approved Date
- 09/24/1996
Available intermediates
2 intermediates currently listed for Ropivacaine Hydrochloride Hydrate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide | 15883-20-2 | / | / |
| (2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide | 27262-40-4 | / | / |
Other programs under R
Building toward Ropivacaine Hydrochloride Hydrate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →